{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:02:44Z","timestamp":1789524164220,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08075-2","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:10:01Z","timestamp":1751404201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Aspirin improves short and long term survival outcomes of patients with sepsis associated encephalopathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Qian-qian","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-nan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-yu","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"6","key":"8075_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jama.1996.03530300054040","volume":"275","author":"LA Eidelman","year":"1996","unstructured":"Eidelman, L. A., Putterman, D., Putterman, C. & Sprung, C. L. The spectrum of septic encephalopathy: Definitions, etiologies, and mortalities. JAMA 275(6), 470\u2013473 (1996).","journal-title":"JAMA"},{"issue":"11\u201312","key":"8075_CR2","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1177\/0885066617719750","volume":"34","author":"Q Feng","year":"2019","unstructured":"Feng, Q. et al. Characterization of sepsis and sepsis-associated encephalopathy. J. Intens. Care Med. 34(11\u201312), 938\u2013945 (2019).","journal-title":"J. Intens. Care Med."},{"issue":"10","key":"8075_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrneurol.2012.183","volume":"8","author":"TE Gofton","year":"2012","unstructured":"Gofton, T. E. & Young, G. B. Sepsis-associated encephalopathy. Nat. Rev. Neurol. 8(10), 557\u2013566 (2012).","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"8075_CR4","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1007\/s12035-021-02303-2","volume":"58","author":"AV Catarina","year":"2021","unstructured":"Catarina, A. V., Branchini, G., Bettoni, L., De Oliveira, J. R. & Nunes, F. B. Sepsis-associated encephalopathy: From pathophysiology to progress in experimental studies. Mol. Neurobiol. 58(6), 2770\u20132779 (2021).","journal-title":"Mol. Neurobiol."},{"key":"8075_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.834649","volume":"13","author":"L Bourhy","year":"2022","unstructured":"Bourhy, L. et al. Neuro-inflammatory response and brain-peripheral crosstalk in sepsis and stroke. Front. Immunol. 13, 834649 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"8075_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nri.2016.123","volume":"17","author":"B Becher","year":"2017","unstructured":"Becher, B., Spath, S. & Goverman, J. Cytokine networks in neuroinflammation. Nat. Rev. Immunol. 17(1), 49\u201359 (2017).","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"8075_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s12028-019-00759-8","volume":"32","author":"G Orhun","year":"2020","unstructured":"Orhun, G. et al. Brain volume changes in patients with acute brain dysfunction due to sepsis. Neurocrit. Care 32(2), 459\u2013468 (2020).","journal-title":"Neurocrit. Care"},{"issue":"5","key":"8075_CR8","first-page":"828","volume":"125","author":"LN Zhang","year":"2012","unstructured":"Zhang, L. N. et al. Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients: 2008\u20132011. Chin. Med. J. (Engl.) 125(5), 828\u2013831 (2012).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"8075_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40560-020-00459-y","volume":"8","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. Development of a nomogram to predict 30-day mortality of patients with sepsis-associated encephalopathy: A retrospective cohort study. J. Intens. Care 8, 45 (2020).","journal-title":"J. Intens. Care"},{"issue":"16","key":"8075_CR10","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin, G. S., Mannino, D. M., Eaton, S. & Moss, M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348(16), 1546\u20131554 (2003).","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"8075_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/jim-2016-000374","volume":"65","author":"FG Rothenberg","year":"2017","unstructured":"Rothenberg, F. G., Clay, M. B., Jamali, H. & Vandivier-Pletsch, R. H. Systematic review of beta blocker, aspirin, and statin in critically ill patients: importance of severity of illness and cardiac troponin. J. Investig. Med. 65(4), 747\u2013753 (2017).","journal-title":"J. Investig. Med."},{"issue":"2","key":"8075_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/01.CCM.0000153520.31562.48","volume":"33","author":"JF Dhainaut","year":"2005","unstructured":"Dhainaut, J. F. et al. Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure. Crit. Care Med. 33(2), 341\u2013348 (2005).","journal-title":"Crit. Care Med."},{"issue":"6","key":"8075_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/SHK.0000000000001057","volume":"49","author":"F Du","year":"2018","unstructured":"Du, F., Jiang, P., He, S., Song, D. & Xu, F. Antiplatelet therapy for critically ill patients: A pairwise and bayesian network meta-analysis. Shock 49(6), 616\u2013624 (2018).","journal-title":"Shock"},{"issue":"5","key":"8075_CR14","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00134-015-3760-y","volume":"41","author":"MJ Tsai","year":"2015","unstructured":"Tsai, M. J. et al. Association of prior antiplatelet agents with mortality in sepsis patients: a nationwide population-based cohort study. Intens. Care Med. 41(5), 806\u2013813 (2015).","journal-title":"Intens. Care Med."},{"key":"8075_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/720254","volume":"2012","author":"W Losche","year":"2012","unstructured":"Losche, W. et al. Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients?. Thrombosis 2012, 720254 (2012).","journal-title":"Thrombosis"},{"issue":"6","key":"8075_CR16","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1097\/CCM.0b013e318246b9df","volume":"40","author":"DP Eisen","year":"2012","unstructured":"Eisen, D. P., Reid, D. & McBryde, E. S. Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit. Care Med. 40(6), 1761\u20131767 (2012).","journal-title":"Crit. Care Med."},{"key":"8075_CR17","doi-asserted-by":"publisher","first-page":"1186384","DOI":"10.3389\/fphar.2023.1186384","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. Aspirin reduces the mortality risk of sepsis-associated acute kidney injury: An observational study using the MIMIC IV database. Front. Pharmacol. 14, 1186384 (2023).","journal-title":"Front. Pharmacol."},{"key":"8075_CR18","doi-asserted-by":"publisher","first-page":"1402386","DOI":"10.3389\/fphar.2024.1402386","volume":"15","author":"G Wang","year":"2024","unstructured":"Wang, G. et al. Aspirin reduces the mortality risk of patients with community-acquired pneumonia: A retrospective propensity-matched analysis of the MIMIC-IV database. Front. Pharmacol. 15, 1402386 (2024).","journal-title":"Front. Pharmacol."},{"issue":"8","key":"8075_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8), 801\u2013810 (2016).","journal-title":"JAMA"},{"issue":"1","key":"8075_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/CCM.0b013e3181b4275c","volume":"38","author":"J Winning","year":"2010","unstructured":"Winning, J. et al. Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit. Care Med. 38(1), 32\u201337 (2010).","journal-title":"Crit. Care Med."},{"key":"8075_CR21","doi-asserted-by":"publisher","first-page":"1292745","DOI":"10.3389\/fphar.2023.1292745","volume":"14","author":"Y Meng","year":"2023","unstructured":"Meng, Y. et al. Aspirin intervention before ICU admission reduced the mortality in critically ill patients with acute kidney injury: results from the MIMIC-IV. Front. Pharmacol. 14, 1292745 (2023).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"8075_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/cc11886","volume":"17","author":"M Sossdorf","year":"2013","unstructured":"Sossdorf, M., Otto, G. P., Boettel, J., Winning, J. & Losche, W. Benefit of low-dose aspirin and non-steroidal anti-inflammatory drugs in septic patients. Crit. Care 17(1), 402 (2013).","journal-title":"Crit. Care"},{"issue":"2 Suppl","key":"8075_CR23","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/CCM.0b013e3181c9e31d","volume":"38","author":"S Gando","year":"2010","unstructured":"Gando, S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit. Care Med. 38(2 Suppl), S35-42 (2010).","journal-title":"Crit. Care Med."},{"issue":"5 Suppl","key":"8075_CR24","doi-asserted-by":"publisher","first-page":"S313","DOI":"10.1097\/00003246-200205001-00022","volume":"30","author":"JL Vincent","year":"2002","unstructured":"Vincent, J. L., Yagushi, A. & Pradier, O. Platelet function in sepsis. Crit. Care Med. 30(5 Suppl), S313-317 (2002).","journal-title":"Crit. Care Med."},{"issue":"21","key":"8075_CR25","doi-asserted-by":"publisher","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","volume":"92","author":"J Claria","year":"1995","unstructured":"Claria, J. & Serhan, C. N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. USA 92(21), 9475\u20139479 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"8075_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan, C. N., Chiang, N. & Van Dyke, T. E. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8(5), 349\u2013361 (2008).","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"8075_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10555-017-9675-z","volume":"36","author":"A Ornelas","year":"2017","unstructured":"Ornelas, A. et al. Beyond COX-1: The effects of aspirin on platelet biology and potential mechanisms of chemoprevention. Cancer Metastasis Rev. 36(2), 289\u2013303 (2017).","journal-title":"Cancer Metastasis Rev."},{"issue":"2","key":"8075_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/bcpt.13308","volume":"127","author":"KM Mirabito Colafella","year":"2020","unstructured":"Mirabito Colafella, K. M., Neuman, R. I., Visser, W., Danser, A. H. J. & Versmissen, J. Aspirin for the prevention and treatment of pre-eclampsia: A matter of COX-1 and\/or COX-2 inhibition?. Basic Clin. Pharmacol. Toxicol. 127(2), 132\u2013141 (2020).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"5174","key":"8075_CR29","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.8052854","volume":"265","author":"E Kopp","year":"1994","unstructured":"Kopp, E. & Ghosh, S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265(5174), 956\u2013959 (1994).","journal-title":"Science"},{"issue":"6706","key":"8075_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/23948","volume":"396","author":"MJ Yin","year":"1998","unstructured":"Yin, M. J., Yamamoto, Y. & Gaynor, R. B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396(6706), 77\u201380 (1998).","journal-title":"Nature"},{"issue":"57","key":"8075_CR31","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1038\/sj.onc.1208169","volume":"23","author":"Y Takada","year":"2004","unstructured":"Takada, Y., Bhardwaj, A., Potdar, P. & Aggarwal, B. B. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 23(57), 9247\u20139258 (2004).","journal-title":"Oncogene"},{"issue":"11","key":"8075_CR32","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1182\/blood.V86.11.4144.bloodjournal86114144","volume":"86","author":"P Oeth","year":"1995","unstructured":"Oeth, P. & Mackman, N. Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells. Blood 86(11), 4144\u20134152 (1995).","journal-title":"Blood"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08075-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08075-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08075-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:10:02Z","timestamp":1751404202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08075-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8075"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08075-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The data in this study were from two public de-identified databases. After completing Collaborative Institutional Training Initiative (CITI program), we got permission to access the database (Record ID: 36067767). This study involves human participants but the Ethics Committee(s) or Institutional Board(s) exempted this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"22242"}}